Medicine
Lexiscan 0.4 mg/5 mL injection
Lexiscan 0.4 mg/5 mL injection is a prescription medicine containing Regadenoson for intravenous use, marketed by Astellas Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature, 25°C (77°F), excursions permitted to 15°…
Key facts
- Active ingredient (INN)
- Regadenoson
- Brand
- Lexiscan
- Strength
- 0.4 mg/5 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 5 mL
- Marketing authorisation holder
- Astellas Pharma
- Manufacturer
- Astellas Pharma
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature, 25°C (77°F), excursions permitted to 15° to 30°C (59°– 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C01EB21 Regadenoson
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 April 2008
- Identifiers
- DailyMed set ID 057289f4-2e18-4c1e-bed4-6c1858e2ef16NDC 0469-6501Application NDA022161
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 mL in 1 syringe, plastic | 0469-6501-89 | Astellas Pharma | 10 April 2008 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Regadenoson 0.4 mg/5 mL injection.
Other strengths and forms of Regadenoson
Clinical summary
Regadenoson is a pharmacologic cardiac stress test agent indicated for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress. It is available as injection for intravenous use. MedsAcross supplies Regadenoson for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about RegadenosonFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- LEXISCAN prescribing information (Astellas Pharma) · U.S. National Library of Medicine, DailyMed
- Rapiscan: European public assessment report (EPAR) · European Medicines Agency
Need Lexiscan 0.4 mg/5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.